Interferon alpha-n1Alternative Names: Wellferon
Latest Information Update: 06 Nov 2015
At a glance
- Originator Glaxo Wellcome SA
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Registered Hepatitis C
- Market Withdrawal Cancer; Chronic myeloid leukaemia; Condylomata acuminata; Hairy cell leukaemia; Hepatitis B; Recurrent respiratory papillomatosis